Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients
AUTHORS
Talbot
HK ,
Dunning
AJ ,
Robertson
CA ,
Landolfi
VA ,
Greenberg
DP ,
DiazGranados
CA ,
. Open forum infectious diseases. 2018 5 22; 5(6). ofy115
- PMID: 29942820 [PubMed].
- PMCID: PMC6007273.
ABSTRACT
Passive surveillance data had signaled the possibility of gastrointestinal adverse events occurring after the administration of high-dose inactivated influenza vaccine (IIV-HD). However, in a large, prospective randomized clinical trial, rates of serious gastrointestinal events were no greater among IIV-HD recipients than among those who received a standard-dose influenza vaccine.
Tags: Alumni Publications 2018